Kenney Stephanie (CIK 2105422) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-22). Recent activity: Sell RNA (2,375 shares), Buy RNA (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-22 | Atrium Therapeutics, Inc. (RNA) | Chief Corporate Affairs Officer | Sell | 2,375 | $21,256 |
| 2026-04-22 | Atrium Therapeutics, Inc. (RNA) | Chief Corporate Affairs Officer | Buy | 30,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-22